Global /China /Healthcare /Drug Manufacturers - General /300485
chevron_leftBack
Beijing Science Sun Pharmaceutical Co., Ltd. logo

Beijing Science Sun Pharmaceutical Co., Ltd.

300485
SHE: 300485 Delayed
10.91CNY -0.8%
1.61 USD
As of 15 June 2026, Beijing Science Sun Pharmaceutical Co., Ltd. has a market cap of $781.93M USD, ranking #12185 globally and #3600 in China. It ranks #1110 in the Healthcare sector, and #413 in the Drug Manufacturers - General industry.
Global Rank
12185
Country Rank
3600
Sector Rank
1110
Industry Rank
413
Key Stats
Market Cap
$781.93MUSD
5.3B CNY
Enterprise Value
$558.21MUSD
3.78B CNY
Revenue (TTM)
$59.73MUSD
404.72M CNY
EBITDA (TTM)
$4.38MUSD
29.66M CNY
Net Income (TTM)
$2.15MUSD
14.57M CNY
EBITDA Margin
7.3%
Profit Margin
3.6%
PE Ratio
363.6
PS Ratio
13.1
PB Ratio
1.6
EV/EBITDA
125.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Biao Ma open_in_new
Employees
489
Founded
1999
Website
ssyy.com.cn open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.8% -5.2% 1% -2.2% -9% 35%

News

Loading...

Markets

Exchange Ticker Price
Shenzhen Stock Exchange
MIC: XSHE
PRIMARY
300485
北京赛升药业股份有限公司 Class A
ISIN: CNE100002110
Shares Out.:
481.666M1 Shares Float: 350.997M2
TV:
SA:
YF:
GF:
BA:
MS:
10.91 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Beijing Science Sun Pharmaceutical Co., Ltd.

Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of injections in China. The company offers products for cardiovascular, cerebrovascular, immunomodulation, and nervous systems, and other drugs. It is also involved in raw materials, solid oral preparations, and health products; extraction of traditional Chinese medicine; manufacture of Chinese and Western medicine preparations; research, development, production, and sales of tablets, hard capsules, powders, granules, and active pharmaceutical ingredients; outward investment, technology introduction and exchange, international business development, livestock and poultry production, and research and development of bio-organic fertilizers and bio-feeds. In addition, the company is engaged venture capital; equity investment through private equity funds; technology development, transfer, and services for biological products, pharmaceuticals, diagnostic reagents, and medical devices; biotechnology information consulting; sales of immunoassay reagents and laboratory instruments; research, development and industrialization of human vaccines; investment management and consulting for non-securities businesses, as well as inspection and testing services, consulting services, and health food production. The company was founded in 1999 and is headquartered in Beijing, China.

Similar Companies

Industry: Drug Manufacturers - General (China)
Name
Market Cap diff.
PE
$53.85B
364.89B CNY
7K%
44.9
603259
$49.64B
336.36B CNY
6K%
17.2
$28.52B
223.48B HKD
4K%
35.7
$18.8B
147.32B HKD
2K%
162.3
$16.51B
111.89B CNY
2K%
-
9926
$16.01B
125.46B HKD
2K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
97K%
38.1
JNJ
$547.28B
70K%
26.4
ABBV
$360.63B
46K%
97.4
$321.52B
256.25B CHF
41K%
19.9
AZN
$288.84B
215.59B GBP
37K%
27.6
NOVN
$274.65B
218.9B CHF
35K%
20.5
chevron_leftBack